… in breast cancer although … immune checkpoint blockade and potential predictive biomarkers
and emphasise the new strategies that are under clinical development in breast cancer…

… has emerged as a promising treatment strategy, and immune checkpoint inhibition has …
breast cancer. This chapter provides an overview of breast cancer immunobiology and immune-…

… The aims of this review are to: provide an overview of the key early immune checkpoint
inhibitor … a detailed exploration of the status of immune checkpoint inhibitors in breast cancer. …

… the expression of 50 immune checkpoint genes, including … , in different subtypes of breast
cancer and assessed their … 50 immune checkpoint genes were distinct in breast cancer. …

… contributing to immune-evasion. We focus on the immune checkpoint and TME elements
that influence cancer progression, particularly studies in molecular subtypes of breast cancer. …

V-domain Ig suppressor of T cell activation (VISTA) is a novel immune checkpoint that is an
emerging target for cancer immunotherapy. This study aimed to investigate the expression of …

… Integrative breast cancer immunotherapies that strategically combine established breast
cancer therapies with breast cancer vaccines, immune checkpoint blockade or both should …

… presence of immune checkpoint expression, and the microbiome in defining immune
checkpoint blockade response. We will highlight the current immune checkpoint inhibitor treatment …

… patients with metastatic breast cancer following ICI treatment … of immune checkpoint therapy
in metastatic breast cancer, … breast cancer had a better response to immune checkpoint …

… in cancer is the blockade of immune checkpoints. In this review, we discuss the potential of
certain inhibitors of immune checkpoints, such … gene-3 (LAG-3), in breast cancer therapeutics. …